Molecular mechanisms of colistin resistance in klebsiella pneumoniae causing bacteremia from INDIA-A first report

Frontiers in Microbiology

Volumn 7, Issue JAN, 2017, Pages

  Pragasam, Agila K ^a   Shankar, Chaitra ^a   Veeraraghavan, Balaji ^a   Biswas, Indranil ^b   Nabarro, Laura E B ^a   Inbanathan, Francis Y ^a   George, Biju ^a   Verghese, Santhosh ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Colistin; Klebsiella pneumoniae; Polymyxin B; Resistance; Whole genome sequencing

Indexed keywords

CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; CONTROLLED STUDY; DISK DIFFUSION; ENZYME ACTIVITY; GENE DELETION; GENE MUTATION; KLEBSIELLA PNEUMONIAE; MCR 1 GENE; MCR 2 GENE; MGRB GENE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; WHOLE GENOME SEQUENCING;

EID: 85011955298     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.02135     Document Type: Article

References (41)

1. Ah, Y. M., Kim, A. J., and Lee, J. Y. (2014). Colistin resistance in Klebsiella pneumoniae. Int. J. Antimicrob. Agents 44, 8-15. doi: 10.1016/j.ijantimicag.2014.02.016
2. Anandan, S., Damodaran, S., Gopi, R., Bakthavatchalam, Y. D., and Veeraraghavan, B. (2015). Rapid screening for carbapenem resistant organisms: current results and future approaches. J. Clin. Diagn. Res. 9, DM01. doi: 10.7860/JCDR/2015/14246.6530
3. Bagley, S. T. (1985). Habitat association of Klebsiella species. Infect. Control 6, 52-58. doi: 10.1017/S0195941700062603
4. Balaji, V., Jeremiah, S. S., and Baliga, P. R. (2011). Polymyxins: antimicrobial susceptibility concerns and therapeutic options. Indian J. Med. Microbiol. 29, 230. doi: 10.4103/0255-0857.83905
5. Behera, B., Mathur, P., Das, A., Kapil, A., Gupta, B., Bhoi, S., et al. (2010). Evaluation of susceptibility testing methods for polymyxin. Int. J. Infect. Dis. 14, e596-e601. doi: 10.1016/j.ijid.2009.09.001
6. Cannatelli, A., Di Pilato, V., Giani, T., Arena, F., Ambretti, S., Gaibani, P., et al. (2014). In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment. Antimicrob. Agents Chemother. 58, 4399-4403. doi: 10.1128/AAC.02555-14
7. Carmeli, Y., Akova, M., Cornaglia, G., Diakos, G. L., Garau, J., Harbarth, S., et al. (2010). Controlling the spread of carbapenemase-producing gram-negatives: therapeutic approach and infection control. Clin. Microbiol. Infect. 16, 102-111. doi: 10.1111/j.1469-0691.2009.03115.x
8. Cheng, H. Y., Chen, Y. F., and Peng, H. L. (2010). Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43. J. Biomed. Sci. 17, 1. doi: 10.1186/1423-0127-17-60
9. Clinical Laboratory Standards Institute (CLSI) (2013). Performance Standards for Antimicrobial Susceptibility Testing; Twenty Third Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute. CLSI document M100-S23.
10. Clinical Laboratory Standards Institute (CLSI) (2014). Performance Standards for Antimicrobial Susceptibility Testing; Twenty Fourth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute. CLSI document M100-S24.
11. Clinical Laboratory Standards Institute (CLSI) (2015). Performance Standards for Antimicrobial Susceptibility testing; Twenty Fifth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute. CLSI document M100-S25.
12. Dao, T. T., Liebenthal, D., Tran, T. K., Vu, B. N. T., Nguyen, D. N. T., Tran, H. K. T., et al. (2014). Klebsiella pneumoniae oropharyngeal carriage in rural and urban Vietnam and the effect of alcohol consumption. PLoS ONE 9:e91999. doi: 10.1371/journal.pone.0091999
13. Di Pilato, V., Arena, F., Tascini, C., Cannatelli, A., De Angelis, L. H., Fortunato, S., et al. (2016). MCR-1.2, a New mcr variant carried on a transferable plasmid from a colistin-resistant KPC carbapenemase-producing Klebsiella pneumoniae strain of sequence type 512. Antimicrob. Agents Chemother. 60, 5612-5615. doi: 10.1128/AAC.01075-16
14. Falagas, M. E., and Kasiakou, S. K. (2006). Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit. Care 10, 1. doi: 10.1186/cc3995
15. Falagas, M. E., Kasiakou, S. K., and Saravolatz, L. D. (2005). Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40, 1333-1341. doi: 10.1086/429323
16. Falagas, M. E., Rafailidis, P. I., and Matthaiou, D. K. (2010). Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist. Updat. 13, 132-138. doi: 10.1016/j.drup.2010.05.002
17. Hindler, J. A., and Humphries, R. M. (2013). Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J. Clin. Microbiol. 51, 1678-1684. doi: 10.1128/JCM.03385-12
18. Humphries, R. M. (2015). Susceptibility testing of the polymyxins: where are we now? Pharmacotherapy 35, 22-27. doi: 10.1002/phar.1505
19. Jayol, A., Poirel, L., Brink, A., Villegas, M. V., Yilmaz, M., and Nordmann, P. (2014). Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob. Agents Chemother. 58, 4762-4766. doi: 10.1128/AAC.00084-14
20. Jayol, A., Poirel, L., Villegas, M. V., and Nordmann, P. (2015). Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca. Int. J. Antimicrob. Agents 46, 108-110. doi: 10.1016/j.ijantimicag.2015.02.015
21. Liu, Y. Y., Wang, Y., Walsh, T. R., Yi, L. X., Zhang, R., Spencer, J., et al. (2016). Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16, 161-168. doi: 10.1016/S1473-3099(15)00424-7
22. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., et al. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268-281. doi: 10.1111/j.1469-0691.2011.03570.x
23. Mammina, C., Bonura, C., Di Bernardo, F., Aleo, A., Fasciana, T., Sodano, C., et al. (2012). Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011. Euro Surveill. 17:20248.
24. Nordmann, P., Poirel, L., and Dortet, L. (2012). Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerging Infect. Dis. 18, 1503-1507. doi: 10.3201/eid1809.120355
25. Olaitan, A. O., Diene, S. M., Kempf, M., Berrazeg, M., Bakour, S., Gupta, S. K., et al. (2014). Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int. J. Antimicrob. Agents 44, 500-507. doi: 10.1016/j.ijantimicag.2014.07.020
26. Paczosa, M. K., and Mecsas, J. (2016). Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol. Mol. Biol. Rev. 80, 629-661. doi: 10.1128/MMBR.00078-15
27. Poirel, L., Jayol, A., Bontron, S., Villegas, M. V., Ozdamar, M., Türkoglu, S., et al. (2015). The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J. Antimicrob. Chemother. 70, 75-80. doi: 10.1093/jac/dku323
28. QYResearch Medical Research Centre (2015). The Global Polymyxin Industry Report 2015. Available online at: http://www.qyresearch.com
29. Rock, C., Thom, K. A., Masnick, M., Johnson, J. K., Harris, A. D., and Morgan, D. J. (2014). Frequency of Klebsiella pneumoniae Carbapenemase (KPC)-producing and Non-KPC-producing klebsiella species contamination of healthcare workers and the environment. Infect. Control Hosp. Epidemiol. 35, 426-429. doi: 10.1086/675598
30. Storm, D. R., Rosenthal, K. S., and Swanson, P. E. (1977). Polymyxin and related peptide antibiotics. Annu. Rev. Biochem. 46, 723-763. doi: 10.1146/annurev.bi.46.070177.003451
31. Tan, T. Y., and Ng, L. S. Y. (2006). Comparison of three standardized disc susceptibility testing methods for colistin. J. Antimicrob. Chemother. 58, 864-867. doi: 10.1093/jac/dkl330
32. Tan, T. Y., Ng, L. S. Y., Tan, E., and Huang, G. (2007). In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates. J. Antimicrob. Chemother. 60, 421-423. doi: 10.1093/jac/dkm178
33. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). (2013). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 3.0. Available online at: http://www.eucast.org
34. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2014). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 4.0. Available online at: http://www.eucast.org
35. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2015). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 5.0. Available online at: http://www.eucast.org
36. van der Heijden, I. M., Levin, A. S., De Pedri, E. H., Fung, L., Rossi, F., Duboc, G., et al. (2007). Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins. Ann. Clin. Microbiol. Antimicrob. 6:1. doi: 10.1186/1476-0711-6-1
37. Versalovic, J., Carroll, K. C., Funke, G., Jorgensen, J. H., Landry, M. L., and Warnock, D. W. (2011). Manual of Clinical Microbiology, 10th Edn. Washington, DC: American Society for Microbiology.
38. Velkov, T., Deris, Z. Z., Huang, J. X., Azad, M. A. K., Butler, M., Sivanesan, S., et al. (2013). Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae. Innate Immun. 20, 350-363. doi: 10.1177/1753425913493337
39. Wright, M. S., Suzuki, Y., Jones, M. B., Marshall, S. H., Rudin, S. D., Van Duin, D., et al. (2015). Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob. Agents Chemother. 59, 536-543. doi: 10.1128/AAC.04037-14
40. Xavier, B. B., Lammens, C., Ruhal, R., Kumar-Singh, S., Butaye, P., Goossens, H., et al. (2016). Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium. Euro Surveill. 21:30280. doi: 10.2807/1560-7917.ES.2016.21.27.30280
41. Yahav, D., Farbman, L., Leibovici, L., and Paul, M. (2012). Colistin: new lessons on an old antibiotic. Clin. Microbiol. Infect. 18, 18-29. doi: 10.1111/j.1469-0691.2011.03734.x